Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 16, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Newman Maintained (APTO) at Strong Buy with Decreased Target to $6 on, May 16th, 2024
John Newman of Canaccord Genuity, Maintained "Aptose Biosciences Inc." (APTO) at Strong Buy with Decreased Target from $15 to $6 on, May 16th, 2024.
John has made no other calls on APTO in the last 4 months.
There are 2 other peers that have a rating on APTO. Out of the 2 peers that are also analyzing APTO, 0 agree with John's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with John
- Edward Tenthoff of "Piper Sandler" Maintained at Buy and Held Target at $5 on, Wednesday, April 3rd, 2024
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $23 on, Wednesday, March 27th, 2024
